Is Aflac (AFL) overvalued or fairly valued?

MarketChacha shows Aflac's valuation in context — a trailing P/E of about 15.3, a forward P/E of about 15.7, a price-to-book of about 2.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Aflac's revenue?

Aflac reported revenue of $17.2B for FY2025, with net profit of $3.6B, per official filings.

What is the share price of Aflac (AFL)?

Aflac last traded at $119.72 (+0.9% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

Aflac

AFL · NYSE · Financials · United States

Snapshot

TickerAFL

ExchangeNYSE

SectorFinancials

IndustryInsurance - Life

CountryUnited States

Employees12,716

HeadquartersColumbus, United States

Websitewww.aflac.com

Filings tracked15

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Who owns it

Insiders10.9%
Institutions60.0%
Public & other29.1%

2,127 institutional holders

Ownership breakdown from public market data.

Top holders

Japan Post Holdings Co., Ltd.10.15%
Blackrock Inc.6.96%
Vanguard Capital Management LLC5.96%
Vanguard Portfolio Management LLC4.86%
State Street Corporation4.69%
Geode Capital Management, LLC2.11%
Wells Fargo & Company1.72%
Morgan Stanley1.60%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Over 3 years only 0.61× of reported profit became operating cash — the classic sign that headline earnings may be running ahead of the cash actually generated. Often explained by working capital funding growth; worth a closer look.

Cash conversion0.61×

Net margin trend24.9% → 21.2%

Margin has compressed by about 3.7 points over the period — profitability is trending down.

Growth qualityrev -4% · PAT -12%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $4.3B · EPS 1.73

Est. earnings growth +10.2%

Next fiscal year

Rev $17.2B · EPS 7.62

Est. earnings growth +8.4%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$17.2B

Net margin

21.2%

ROE

12.4%

Revenue CAGR (2y)

-4.2%

Profit CAGR (2y)

-11.5%

EPS (FY2025)

6.82

Net profit (FY2025)

$3.6B

Ask MarketChacha about AFL

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$17.2B	$3.6B	6.82	21.2%	12.4%
FY2024	$18.9B	$5.4B	9.63	28.8%	20.9%
FY2023	$18.7B	$4.7B	7.78	24.9%	21.2%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$4.1B	$825.0M	1.63	20.0%
2026Q1	$4.3B	$1.0B	1.98	23.4%
2025Q3	$4.7B	$1.6B	3.08	34.6%
2025Q2	$4.2B	$599.0M	1.11	14.4%
2025Q1	$3.4B	$29.0M	0.05	0.9%
2024Q3	$2.9B	$-93.0M	-0.17	-3.2%
2024Q2	$5.1B	$1.8B	3.10	34.2%
2024Q1	$5.4B	$1.9B	3.25	34.6%
2023Q4	$3.8B	—	0.46	—
2023Q3	$5.0B	$1.6B	2.64	31.7%
2023Q2	$5.2B	$1.6B	2.71	31.6%
2023Q1	$4.8B	$1.2B	1.94	24.8%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC8/7/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC8/6/2026material
8-K — Other events
SEC6/30/2026material
8-K — Other events, Exhibits
SEC5/28/2026material
8-K — Other events, Exhibits
SEC5/14/2026material
8-K — Shareholder vote results
SEC5/7/2026material
10-Q filing
SEC5/6/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC4/29/2026material
10-K filing
SEC2/25/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC2/4/2026material

2025

10-Q filing
SEC11/5/2025
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC11/4/2025material
8-K — Material financial obligation
SEC8/27/2025material
10-Q filing
SEC8/5/2025
8-K — Results of operations, Exhibits
SEC8/5/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.